Hula Therapeutics
Biotechnology
Philadelphia, Pa, United States
6 employees
- Employees
- 6
- Contacts
- 4
- Emails
- 4
- Phones
- 1
Hula Therapeutics Overview
- Headquarters
- Philadelphia, Pa, United States
- Website
- www.hulatx.com
- Industry
- Biotechnology
- Employees
- 6
- Founded
- 2022
- Funding
- 250.0K
Keywords
About Hula Therapeutics
Hula Therapeutics is an immunotherapy company spinout from the lab of Dr, John Maris at Children’s Hospital of Philadelphia (CHOP). Hula is leveraging deep expertise to identify unique, functionally relevant, and essential tumor specific targets and make them accessible to precision therapeutics (e.g. cell therapy, T-cell engagers, bi-specifics, antibody drug conjugates) for the treatment of adults and children with solid cancers.
Hula Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 4
- Email contacts
- 4
- 100.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Hula Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Matthew Beasley | Cso & Co-founder at Myrio Tx | Greater Melbourne Area, Australia |
Email
|
| Nicole Dressel, Mba, PMP | Wayne, Pennsylvania, United States |
Email
|
|
| Steven Gelone | CEO | United States |
Email
Phone
|
| Mark Yarmarkovich, Phd | Principal Investigator & Assistant Professor at Nyu School of Medicine | New York, United States |
Email
|
Employees by Management Level
Executive
2 profiles
Senior / Lead
1 profile
Compare Similar Companies to Hula Therapeutics
Stealth Mode Biotech
Biotechnology Research
Strados Labs
Medical Device
Carisma Therapeutics
Biotechnology Research
Verismo Therapeutics
Biotechnology Research
Nabriva Therapeutics plc
Biotechnology Research
Kineticos Life Sciences
Venture Capital And Private Equity Principals
Spirovant Sciences, Inc.
Biotechnology Research
ThirdLaw Molecular
Biotechnology Research
Eliksa Therapeutics
Biotechnology Research
Tantigen Bio
Biotechnology Research